<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[333, 334] RFS<br>[340, 341] OS<br></td>
<td width=33%>
[333, 334] RFS<br>[340, 341] OS<br></td>
<td width=33%>
[70, 84] the analyses of each individual trial and to analyze prognostic factors and treatment effects<br>[92, 96] Survival and disease status<br>[102, 107] Analysis of prognostic factors using<br>[126, 133] Analysis of treatment effects versus observation (<br>[218, 229] relapse-free survival (RFS)-but not overall survival (OS)-was<br>[261, 264] RFS and OS<br>[293, 294] RFS<br>[305, 306] OS<br>[332, 341] improved RFS and evidence for moderate improvement in OS<br></td>
</tr>
